ClinicalTrials.Veeva

Menu

Acute Bronchiolitis in Infants and Allergic Asthma

U

University Hospital, Clermont-Ferrand

Status

Unknown

Conditions

Asthma
Acute Bronchiolitis
Allergy

Treatments

Diagnostic Test: Pneumological evaluation

Study type

Interventional

Funder types

Other

Identifiers

NCT03915197
CHU-433
2018-A02659-46 (Other Identifier)

Details and patient eligibility

About

Predicting the risk of allergenic sensitizations and asthma development in the first year of life is difficult.

Investigator decided to follow prospectively two cohorts of infants with acute bronchiolitis, hospitalized or treated at home, from the epidemic seasons of 2011-2012 and 2015-2017 to know their respiratory evolution, especially if they developed allergen sensitization and / or asthma.

Full description

Follow-up consultation 6 years after an episode of acute bronchiolitis at Clermont-Ferrand hospital with:

  • Consultation with a pneumopediatrician: collection of respiratory symptoms, respiratory treatments, evaluation of the atopic site and environmental risk factors for bronchial aggression, especially passive smoking;
  • Physical examination ;
  • Evaluation of precariousness during the same interview with the EPICES questionnaire;
  • Prick tests with positive control (histamine) and negative (physiological saline) and prick for the main pneumallergens (mites, alternaria, grasses, cat and dog) and trophallergens (egg, milk, fish, soy, wheat, peanut);
  • Blood test with blood count, determination of specific IgE (5 pneumallergens and 5 trophallergens), dosage of sRAGE;
  • Fonctionnal respiratory test with reversibility test

Enrollment

320 estimated patients

Sex

All

Ages

7 to 9 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute bronchiolitis in an infant less than one year old, included in studies KL6 (winter period 2011-2012) or CC16 (winter period 2015-2016) at clermont-ferrand hospital.

Exclusion criteria

  • Bronchopulmonary dysplasia;
  • History of prematurity <34 AS;
  • Mucoviscidosis;
  • known immune deficiencies;
  • Primary ciliary dyskinesia suspected;
  • Congenital heart disease;
  • Acute renal failure.
  • Refusal of parents to participate

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

320 participants in 1 patient group

group 1
Experimental group
Description:
cohorts of infants with acute bronchiolitis
Treatment:
Diagnostic Test: Pneumological evaluation

Trial contacts and locations

1

Loading...

Central trial contact

Lise LACLAUTRE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems